Efficacy and Safety of Imatinib in Chordoma
NCT00150072
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Chordoma
Interventions
DRUG:
imatinib
Sponsor
Novartis Pharmaceuticals